Opinion: Instead of paying Big Pharma, Canada should develop its own rare-disease treatments

The process of DNA sequencing has been declining in cost and increasing in speed, and our medical research initiatives should reflect that

Related Keywords

Ottawa ,Ontario ,Canada ,Canadian ,Canadians ,John Bell ,Alex Mackenzie ,Ottawa Hospital Research Institute ,University Of Ottawa ,Life Sciences Strategy ,Canadian Biomanufacturing ,Noastack ,Disease ,Dna ,University ,Professor ,Visma ,One Third ,Diseases ,